Reuters logo
BRIEF-Oncopeptides receives additional patent protection for Ygalo in Europe
March 21, 2017 / 7:49 AM / 9 months ago

BRIEF-Oncopeptides receives additional patent protection for Ygalo in Europe

March 21 (Reuters) - Oncopeptides AB:

* European patent office recently issued a notice that they intend to grant an additional European patent to Oncoeptides

* Additional patent protection for Ygalo is valid April 2032

* Patent (EP2701720) covers inter alia lyophilized formulation of Ygalo that is intended to be launched Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below